Sign Up to like & get recommendations! 0
Published in 2019 at "American Journal of Obstetrics and Gynecology"
DOI: 10.1016/j.ajog.2018.12.008
Abstract: Objective Data Amenorrhea is a polarizing noncontraceptive effect of the levonorgestrel intrauterine system. Composite amenorrhea prevalence estimates that summarize all clinical data for the first-year after insertion currently are not available. The purpose of this… read more here.
Sign Up to like & get recommendations! 0
Published in 2020 at "American journal of obstetrics and gynecology"
DOI: 10.1016/j.ajog.2020.01.014
Abstract: OBJECTIVE To systematically review the literature to determine if extended use of intrauterine devices including the copper or levonorgestrel intrauterine device beyond approved durations is effective and safe for preventing pregnancy. DATA SOURCES We searched… read more here.
Sign Up to like & get recommendations! 1
Published in 2017 at "Contraception"
DOI: 10.1016/j.contraception.2016.11.008
Abstract: This case series reports on the safety and efficacy of the levonorgestrel 52-mg intrauterine system in adolescent and young adult solid organ transplant recipients. All patients used the device for contraception, with no documented cases… read more here.
Sign Up to like & get recommendations! 0
Published in 2017 at "Maturitas"
DOI: 10.1016/j.maturitas.2017.03.210
Abstract: Citation: Antonijuan JR, Escribano G, Domínguez AMA, Borrego RS, Fabregas JP. Levonorgestrel Intrauterine Device and Preservation of Fertility in Endometrial Cancer Grade I: Case Report and Literature Review. Ann Clin Case Rep. 2017; 2: 1440.… read more here.
Sign Up to like & get recommendations! 1
Published in 2021 at "Gynecologic oncology"
DOI: 10.1016/j.ygyno.2021.04.017
Abstract: Endometrial cancer is the most common gynecologic malignancy in developed country. Women under the age of 40 represent 5% of all endometrial cancer and the majority are nulliparous at the time of diagnosis. The aim… read more here.
Sign Up to like & get recommendations! 0
Published in 2019 at "Obstetrics and Gynecology"
DOI: 10.1097/aog.0000000000003034
Abstract: A phase 3 study of a levonorgestrel 52-mg intrauterine system in U.S. females shows high 5-year contraceptive efficacy and low hormonal adverse effect rates. read more here.
Sign Up to like & get recommendations! 0
Published in 2021 at "Journal of Obstetrics and Gynaecology Research"
DOI: 10.1111/jog.15062
Abstract: To evaluate the efficacy of levonorgestrel 52 mg intrauterine system for intermenstrual bleeding in patients with previous cesarean delivery scar defects (PCDSs). read more here.
Sign Up to like & get recommendations! 0
Published in 2020 at "Post Reproductive Health"
DOI: 10.1177/2053369120927887
Abstract: Dear Editor, I found the discussion and proposals made by Manyonda et al. very interesting, particularly their consideration of the potential for using Estrogen-only Replacement Therapy (ERT) with an Levonorgestrel Intrauterine Device (LNG-IUD) to avoid… read more here.